BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 12090431)

  • 1. Lobular neoplasia in breast core needle biopsy specimens is not associated with an increased risk of ductal carcinoma in situ or invasive carcinoma.
    Renshaw AA; Cartagena N; Derhagopian RP; Gould EW
    Am J Clin Pathol; 2002 May; 117(5):797-9. PubMed ID: 12090431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?
    Middleton LP; Grant S; Stephens T; Stelling CB; Sneige N; Sahin AA
    Mod Pathol; 2003 Feb; 16(2):120-9. PubMed ID: 12591964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision.
    Renshaw AA; Derhagopian RP; Martinez P; Gould EW
    Am J Clin Pathol; 2006 Aug; 126(2):310-3. PubMed ID: 16891208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lobular carcinoma in situ/atypical lobular hyperplasia on breast needle biopsies: does it warrant surgical excisional biopsy? A study of 27 cases.
    O'Neil M; Madan R; Tawfik OW; Thomas PA; Fan F
    Ann Diagn Pathol; 2010 Aug; 14(4):251-5. PubMed ID: 20637429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lobular neoplasia on core needle biopsy does not require excision.
    Nagi CS; O'Donnell JE; Tismenetsky M; Bleiweiss IJ; Jaffer SM
    Cancer; 2008 May; 112(10):2152-8. PubMed ID: 18348299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?
    Foster MC; Helvie MA; Gregory NE; Rebner M; Nees AV; Paramagul C
    Radiology; 2004 Jun; 231(3):813-9. PubMed ID: 15105449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of lobular carcinoma in situ and atypical lobular hyperplasia of the breast.
    Lewis JL; Lee DY; Tartter PI
    Ann Surg Oncol; 2012 Dec; 19(13):4124-8. PubMed ID: 22847126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ) diagnosed on core needle biopsy.
    Shah-Khan MG; Geiger XJ; Reynolds C; Jakub JW; Deperi ER; Glazebrook KN
    Ann Surg Oncol; 2012 Oct; 19(10):3131-8. PubMed ID: 22847124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.
    Renshaw AA; Gould EW
    Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical significance of lobular neoplasia on breast core biopsy.
    Karabakhtsian RG; Johnson R; Sumkin J; Dabbs DJ
    Am J Surg Pathol; 2007 May; 31(5):717-23. PubMed ID: 17460455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic findings of follow-up surgical excision for lobular neoplasia on breast core biopsy performed for calcification.
    Zhao C; Desouki MM; Florea A; Mohammed K; Li X; Dabbs D
    Am J Clin Pathol; 2012 Jul; 138(1):72-8. PubMed ID: 22706860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lobular neoplasia on core-needle biopsy--clinical significance.
    Arpino G; Allred DC; Mohsin SK; Weiss HL; Conrow D; Elledge RM
    Cancer; 2004 Jul; 101(2):242-50. PubMed ID: 15241819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
    Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical outcome of biopsy-proven lobular neoplasia: is there any difference between lobular carcinoma in situ and atypical lobular hyperplasia?
    Ibrahim N; Bessissow A; Lalonde L; Mesurolle B; Trop I; Lisbona A; El-Khoury M
    AJR Am J Roentgenol; 2012 Feb; 198(2):288-91. PubMed ID: 22268170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of flat epithelial atypia on mammotome core needle biopsy: Should it be excised?
    Kunju LP; Kleer CG
    Hum Pathol; 2007 Jan; 38(1):35-41. PubMed ID: 17095049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical importance of histologic grading of lobular carcinoma in situ in breast core needle biopsy specimens: current issues and controversies.
    Gao F; Carter G; Tseng G; Chivukula M
    Am J Clin Pathol; 2010 May; 133(5):767-71. PubMed ID: 20395524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is excisional biopsy indicated for patients with lobular neoplasia diagnosed on percutaneous core needle biopsy of the breast?
    Mulheron B; Gray RJ; Pockaj BA; Apsey H
    Am J Surg; 2009 Dec; 198(6):792-7. PubMed ID: 19969131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papillomas and atypical papillomas in breast core needle biopsy specimens: risk of carcinoma in subsequent excision.
    Renshaw AA; Derhagopian RP; Tizol-Blanco DM; Gould EW
    Am J Clin Pathol; 2004 Aug; 122(2):217-21. PubMed ID: 15323138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between core biopsy and excisional biopsy in breast high-risk lesions.
    Margenthaler JA; Duke D; Monsees BS; Barton PT; Clark C; Dietz JR
    Am J Surg; 2006 Oct; 192(4):534-7. PubMed ID: 16978969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.